• 我要登录|
  • 免费注册
    |
  • 我的丁香通
    • 企业机构:
    • 成为企业机构
    • 个人用户:
    • 个人中心
  • 移动端
    移动端
丁香通 logo丁香实验_LOGO
搜实验

    大家都在搜

      大家都在搜

        0 人通过求购买到了急需的产品
        免费发布求购
        发布求购
        点赞
        收藏
        wx-share
        分享

        Anti-K-ras1 Ribozyme Adenoviral Vector for Gene Therapy of Non-Small Cell Lung Cancer

        互联网

        775
        Lung cancer is the leading cause of cancer death for men and women in the United States. Several factors affect survival in nonsmall-cell lung cancer [NSCLC; i.e., stage, age, Karnofsky Performance Status (KPS)]. The 5-yr survival rate is<15% for newly diagnosed cases following conventional treatments. Tumor oncogenetic defects appear to be associated with adverse survival (1 ,2 ). The presence of a ras mutation or p21ras oncoprotein overexpression correlates with an unfavorable prognosis for patients with nonsmall-cell lung cancer (3 ). These findings suggest that abnormal ras function contributes to pathophysiology, and raise the possibility that reversal of aberrant ras activity may serve as a viable therapeutic approach.
        ad image
        提问
        扫一扫
        丁香实验小程序二维码
        实验小助手
        丁香实验公众号二维码
        扫码领资料
        反馈
        TOP
        打开小程序